Skip to main content
. 2018 Mar 1;9:36. doi: 10.3389/fgene.2018.00036

Figure 9.

Figure 9

Aberrant 5mCpG DNA methylation at the new maternal iDMRs in hematopoietic cancers. The 5mCpG DNA methylation statuses at the PARD6G-AS1 and GCSAML iDMRs are perturbed in methylomes of hematopoietic cancers, displaying either hypo- or hypermethylated profiles. Abnormal patterns are also observed at the known PPIEL and DIRAS3 iDMRs, located on chromosome 1, which were used as a reference set. The light blue zone represents the expected intermediate methylation range (0.35–0.65). Each methylome is represented by a different color of bar.